Old dog, new trick: Charybdotoxin as a novel ryanodine receptor blocker
Zsuzsanna Édua Magyar, Judit Hevesi, Frigyes Mészáros, Zsolt Bozsó, János Szolomájer, Gábor Tóth, György Panyi, Péter Enyedi, Zoltán Varga, Zoltán Pethő, János AlmássyAbstract
Ryanodine receptors (RyRs) are Ca 2 + ‐release channels of the sarcoplasmic reticulum. Because uncontrolled Ca 2 + ‐release underlies several muscle and cardiac disorders, pharmacological inhibition of RyRs represents an attractive therapeutic strategy. Natural peptide toxins have provided valuable molecular templates for inhibitor design, with calcins being a particularly promising group. Calcins bind RyRs with high specificity, but, instead of producing the desired full channel block, they stabilize subconductance states that promote Ca 2 + leak. Given the mechanistic similarity between calcins’ action and the well‐known charybdotoxin (ChTX)‐mediated K + channel blockade, we examined whether ChTX showed functional cross‐reactivity with RyR channels. Single‐channel recordings were performed on skeletal muscle RyRs reconstituted into lipid bilayers. ChTX induced long‐lasting (>0.5 s) closed events (LLCEs) in a voltage‐dependent manner with an apparent K d of 85 n
Key points
Charybdotoxin (ChTX) blocks ryanodine receptor (RyR) single channel currents in bilayer recordings. Amino acid residues R25 and R34 are essential for the block. K27, which is important for K+ channel block, is irrelevant in RyR block; thereby, the K27N ChTX variant represents a RyR‐selective blocker. ChTX shares a common binding site with calcin peptides in the channel vestibule, outside the gate.